Haukaas S - Search Results

1

PRSS2 remodels the tumor microenvironment via repression of Tsp1 to stimulate tumor growth and progression.

Sui L, Wang S, Ganguly D, El Rayes TP, Askeland C, Børretzen A, Sim D, Halvorsen OJ, Knutsvik G, Arnes J, Aziz S, Haukaas S, Foulkes WD, Bielenberg DR, Ziemys A, Mittal V, Brekken RA, Akslen LA, Watnick RS. Sui L, et al. Among authors: haukaas s. Nat Commun. 2022 Dec 27;13(1):7959. doi: 10.1038/s41467-022-35649-9. Nat Commun. 2022. PMID: 36575174 Free PMC article.

2

Microvascular proliferation is associated with high tumour blood flow by mpMRI and disease progression in primary prostate cancer.

Børretzen A, Reisæter LAR, Ringheim A, Gravdal K, Haukaas SA, Fasmer KE, Haldorsen IHS, Beisland C, Akslen LA, Halvorsen OJ. Børretzen A, et al. Among authors: haukaas sa. Sci Rep. 2023 Oct 20;13(1):17949. doi: 10.1038/s41598-023-45158-4. Sci Rep. 2023. PMID: 37863961 Free PMC article.

3

The epithelial-mesenchymal transition regulators Twist, Slug, and Snail are associated with aggressive tumour features and poor outcome in prostate cancer patients.

Børretzen A, Gravdal K, Haukaas SA, Mannelqvist M, Beisland C, Akslen LA, Halvorsen OJ. Børretzen A, et al. Among authors: haukaas sa. J Pathol Clin Res. 2021 May;7(3):253-270. doi: 10.1002/cjp2.202. Epub 2021 Feb 19. J Pathol Clin Res. 2021. PMID: 33605548 Free PMC article.

4

FOXC2 expression and epithelial-mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer.

Børretzen A, Gravdal K, Haukaas SA, Beisland C, Akslen LA, Halvorsen OJ. Børretzen A, et al. Among authors: haukaas sa. J Pathol Clin Res. 2019 Oct;5(4):272-286. doi: 10.1002/cjp2.142. Epub 2019 Oct 1. J Pathol Clin Res. 2019. PMID: 31464093 Free PMC article.

5

Clinical and prognostic significance of changes in haemoglobin concentration during 1 year of androgen-deprivation therapy for hormone-naïve bone-metastatic prostate cancer.

Ebbinge M, Berglund A, Varenhorst E, Hedlund PO, Sandblom G; Scandinavian Prostate Cancer Group (SPCG)-5 Study Group. Ebbinge M, et al. BJU Int. 2018 Oct;122(4):583-591. doi: 10.1111/bju.14227. Epub 2018 May 30. BJU Int. 2018. PMID: 29611275 Clinical Trial.

6

Optimising preoperative risk stratification tools for prostate cancer using mpMRI.

Reisæter LAR, Fütterer JJ, Losnegård A, Nygård Y, Monssen J, Gravdal K, Halvorsen OJ, Akslen LA, Biermann M, Haukaas S, Rørvik J, Beisland C. Reisæter LAR, et al. Among authors: haukaas s. Eur Radiol. 2018 Mar;28(3):1016-1026. doi: 10.1007/s00330-017-5031-5. Epub 2017 Oct 6. Eur Radiol. 2018. PMID: 28986636 Free PMC article.

7

A positive Real-Time Elastography (RTE) combined with a Prostate Cancer Gene 3 (PCA3) score above 35 convey a high probability of intermediate- or high-risk prostate cancer in patient admitted for primary prostate biopsy.

Nygård Y, Haukaas SA, Halvorsen OJ, Gravdal K, Frugård J, Akslen LA, Beisland C. Nygård Y, et al. Among authors: haukaas sa. BMC Urol. 2016 Jul 8;16(1):39. doi: 10.1186/s12894-016-0159-1. BMC Urol. 2016. PMID: 27391229 Free PMC article.

8

Prostate cancer antigen-3 (PCA3) and PCA3-based nomograms in the diagnosis of prostate cancer: an external validation of Hansen's nomogram on a Norwegian cohort.

Nygård Y, Haukaas SA, Eide GE, Halvorsen OJ, Gravdal K, Frugård J, Akslen LA, Beisland C. Nygård Y, et al. Among authors: haukaas sa. Scand J Urol. 2015 Feb;49(1):8-15. doi: 10.3109/21681805.2014.949841. Epub 2014 Aug 20. Scand J Urol. 2015. PMID: 25141128

9

1.5-T multiparametric MRI using PI-RADS: a region by region analysis to localize the index-tumor of prostate cancer in patients undergoing prostatectomy.

Reisæter LA, Fütterer JJ, Halvorsen OJ, Nygård Y, Biermann M, Andersen E, Gravdal K, Haukaas S, Monssen JA, Huisman HJ, Akslen LA, Beisland C, Rørvik J. Reisæter LA, et al. Among authors: haukaas s. Acta Radiol. 2015 Apr;56(4):500-11. doi: 10.1177/0284185114531754. Epub 2014 May 12. Acta Radiol. 2015. PMID: 24819231

10

A positive real-time elastography is an independent marker for detection of high-risk prostate cancers in the primary biopsy setting.

Nygård Y, Haukaas SA, Halvorsen OJ, Gravdal K, Frugård J, Akslen LA, Beisland C. Nygård Y, et al. Among authors: haukaas sa. BJU Int. 2014 May;113(5b):E90-7. doi: 10.1111/bju.12401. Epub 2013 Nov 27. BJU Int. 2014. PMID: 24053494

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page